Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada

NCT04398147 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

696

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
BIOLOGICAL: Placebo

Sponsor

CanSino Biologics Inc.

Collaborators

[object Object]
[object Object]